168 related articles for article (PubMed ID: 25641640)
1. The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH.
Azevedo-Silva J; Queirós O; Ribeiro A; Baltazar F; Young KH; Pedersen PL; Preto A; Casal M
Biochem J; 2015 Apr; 467(2):247-58. PubMed ID: 25641640
[TBL] [Abstract][Full Text] [Related]
2. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O
Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066
[TBL] [Abstract][Full Text] [Related]
3. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.
Queirós O; Preto A; Pacheco A; Pinheiro C; Azevedo-Silva J; Moreira R; Pedro M; Ko YH; Pedersen PL; Baltazar F; Casal M
J Bioenerg Biomembr; 2012 Feb; 44(1):141-53. PubMed ID: 22350013
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monocarboxylate transport in human kidney HK-2 cells.
Wang Q; Lu Y; Yuan M; Darling IM; Repasky EA; Morris ME
Mol Pharm; 2006; 3(6):675-85. PubMed ID: 17140255
[TBL] [Abstract][Full Text] [Related]
5. Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications.
Ferro S; Azevedo-Silva J; Casal M; Côrte-Real M; Baltazar F; Preto A
Oncotarget; 2016 Oct; 7(43):70639-70653. PubMed ID: 28874966
[TBL] [Abstract][Full Text] [Related]
6. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.
Pinheiro C; Albergaria A; Paredes J; Sousa B; Dufloth R; Vieira D; Schmitt F; Baltazar F
Histopathology; 2010 Jun; 56(7):860-7. PubMed ID: 20636790
[TBL] [Abstract][Full Text] [Related]
7. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
Su J; Chen X; Kanekura T
Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
[TBL] [Abstract][Full Text] [Related]
8. The Cryptococcus neoformans monocarboxylate transporter Jen4 is responsible for increased 3-bromopyruvate sensitivity.
Niedźwiecka K; Ribas D; Casal M; Ułaszewski S
FEMS Yeast Res; 2019 May; 19(3):. PubMed ID: 30993332
[TBL] [Abstract][Full Text] [Related]
9. Targeting lactate transport suppresses in vivo breast tumour growth.
Morais-Santos F; Granja S; Miranda-Gonçalves V; Moreira AH; Queirós S; Vilaça JL; Schmitt FC; Longatto-Filho A; Paredes J; Baltazar F; Pinheiro C
Oncotarget; 2015 Aug; 6(22):19177-89. PubMed ID: 26203664
[TBL] [Abstract][Full Text] [Related]
10. A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells.
Chen TC; Yu J; Nouri Nigjeh E; Wang W; Myint PT; Zandi E; Hofman FM; Schönthal AH
Cancer Lett; 2017 Aug; 400():161-174. PubMed ID: 28450161
[TBL] [Abstract][Full Text] [Related]
11. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis.
Verhoeven HA; van Griensven LJ
J Bioenerg Biomembr; 2012 Feb; 44(1):91-9. PubMed ID: 22318358
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivities to lactate transport inhibitors of breast cancer cell lines.
Morais-Santos F; Miranda-Gonçalves V; Pinheiro S; Vieira AF; Paredes J; Schmitt FC; Baltazar F; Pinheiro C
Endocr Relat Cancer; 2014 Feb; 21(1):27-38. PubMed ID: 24174370
[TBL] [Abstract][Full Text] [Related]
14. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
[TBL] [Abstract][Full Text] [Related]
15. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
Izumi H; Takahashi M; Uramoto H; Nakayama Y; Oyama T; Wang KY; Sasaguri Y; Nishizawa S; Kohno K
Cancer Sci; 2011 May; 102(5):1007-13. PubMed ID: 21306479
[TBL] [Abstract][Full Text] [Related]
16. CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma.
Pinheiro C; Longatto-Filho A; Soares TR; Pereira H; Bedrossian C; Michael C; Schmitt FC; Baltazar F
Diagn Cytopathol; 2012 Jun; 40(6):478-83. PubMed ID: 22619123
[TBL] [Abstract][Full Text] [Related]
17. A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.
Ko YH; Verhoeven HA; Lee MJ; Corbin DJ; Vogl TJ; Pedersen PL
J Bioenerg Biomembr; 2012 Feb; 44(1):163-70. PubMed ID: 22328020
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of 3-bromopyruvate on the proliferation and the motility of hepatocellular carcinoma cells.
Tomizawa M; Shinozaki F; Motoyoshi Y; Sugiyama T; Yamamoto S; Ishige N
Oncol Rep; 2016 Jan; 35(1):59-63. PubMed ID: 26530887
[TBL] [Abstract][Full Text] [Related]
19. Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting.
Ganapathy-Kanniappan S; Kunjithapatham R; Geschwind JF
Anticancer Res; 2013 Jan; 33(1):13-20. PubMed ID: 23267123
[TBL] [Abstract][Full Text] [Related]
20. 3-Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor André Goffeau.
Ko YH; Niedźwiecka K; Casal M; Pedersen PL; Ułaszewski S
Yeast; 2019 Apr; 36(4):211-221. PubMed ID: 30462852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
